240 mg salicin · vegan · gluten-free · 100 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
White willow bark (Salix alba) is the original source of salicylic acid — the compound from which aspirin (acetylsalicylic acid) was synthesised in 1897. Standardised extracts contain 15% salicin, the glycoside form of salicylic acid. Unlike aspirin, which is rapidly absorbed and can damage the stomach lining, salicin is slowly converted to salicylic acid in the gut and liver, providing gentler, longer-lasting pain relief with minimal gastric irritation.
Salicin is absorbed from the intestine and converted to salicylic acid by gut bacteria and hepatic enzymes. Salicylic acid inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis — the same mechanism as aspirin. However, because the conversion is gradual and salicylic acid is released slowly into the bloodstream, willow bark does not cause the sharp peaks that damage gastric mucosa. It also contains flavonoids and polyphenols that provide additional anti-inflammatory and antioxidant activity not found in synthetic aspirin.
People with low back pain, osteoarthritis, general musculoskeletal pain, headaches and fever benefit most. It is particularly valuable for those who need aspirin-like pain relief but cannot tolerate synthetic NSAIDs due to gastric ulcer risk, bleeding disorders or salicylate sensitivity.
Those with salicylate allergy, aspirin-sensitive asthma, bleeding disorders or on anticoagulants should avoid. Pregnant or breastfeeding women (salicylates cross the placenta and enter breast milk). Children under 16 (Reye's syndrome risk, though lower than with aspirin). Side effects: Generally well tolerated. Mild GI upset, nausea or allergic reactions in salicylate-sensitive individuals. Rare tinnitus at very high doses. Does not cause the gastric bleeding or ulceration associated with aspirin.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: PMID 10936472 (White willow bark in low back pain — n=210 RCT, significant pain reduction, 2000), PMID 25997859 (Meta-analysis of willow bark for musculoskeletal pain — significant efficacy, 2015), PMC10607963 (Willow bark systematic review and meta-analysis — back pain and OA, 2024)
SacredBod's longer take on Willow Bark Standardised — context the structured blocks above don't capture.
White willow bark is the original aspirin. For thousands of years, people chewed willow bark to relieve pain, fever and inflammation. In the 5th century BCE, Hippocrates recommended willow bark for childbirth pain. In 1828, German pharmacologist Johann Büchner isolated the active compound — salicin. In 1897, Felix Hoffmann at Bayer synthesised acetylsalicylic acid (aspirin) from salicin, creating the first synthetic drug.
Standardised white willow bark extract contains 15% salicin — ensuring therapeutic potency. Unlike aspirin, which delivers a rapid bolus of salicylic acid, willow bark releases it gradually through bacterial metabolism in the gut and enzymatic conversion in the liver. This slow-release profile provides sustained pain relief without the gastric damage that makes aspirin notorious.
In India, willow bark is virtually unknown — it is a temperate tree native to Europe and North America. But for Indians seeking a natural aspirin alternative, it is one of the most evidence-based options available.
Willow bark’s analgesic mechanism is identical to aspirin’s at the molecular level, but different at the pharmacokinetic level:
The gradual conversion means no sharp peaks in salicylic acid concentration — and no sharp damage to the gastric mucosa. The 2000 RCT (n=210) demonstrated that willow bark extract was superior to placebo for low back pain with a safety profile far superior to NSAIDs.
Willow bark is generally safe but carries the same cautions as aspirin:
Sanskrit/Hindi name: Not applicable — white willow (Salix alba) is native to Europe, North Africa and western Asia. It does not grow in India and has no classical Ayurvedic name or use.
Availability: White willow bark is not manufactured by Indian brands and is only available as an import:
It is not a Schedule H drug.
Ayurvedic parallel: There is no direct Ayurvedic equivalent to willow bark. However, the concept of “Shoolahara” (pain-relieving) herbs in Charaka Samhita aligns with willow bark’s analgesic function. A modern integrative practitioner might compare willow bark to Jatamansi (Nardostachys jatamansi) for headache relief or Shallaki (Boswellia serrata) for joint pain — though these work through entirely different mechanisms.
Traditional use: Used in European herbal medicine for over 2,000 years. Native American tribes used various Salix species for pain, fever and inflammation. Introduced to modern pharmacology by Hippocrates and later by the Reverend Edward Stone, who rediscovered its fever-reducing properties in 1763.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
